Waveshare has recently introduced ESP32-S3-Touch-LCD-3.49, an ESP32-S3-based wide touch display (640×172) development board ...
Driven by climate change, population mobility and global trade, mosquito-borne diseases are extending beyond tropical and ...
Achieved expedited enrollment completion of first two Cohorts in Phase 1/2 Audiogene clinical trial evaluating SENS-501, the Company’s gene therapy candidate being developed to treat a specific form ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the completion of enrollment for REGENERATE MSA-101, its Phase 1 ...
These fighter jets make up for what they may lack in size with spell-binding mobility. These are the 13 most agile in the ...
The Project is fully permitted to commence drilling, and the Company is fully funded for the proposed exploration program. The 2025 program is designed to follow up on a near-surface Copper/Moly ...
Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...
Nemo Protocol launched its NEOM debt token program to compensate victims of a $2.6 million exploit that devastated the ...
Geochemical soil survey defined a large (~1.0 × 0.7 km), prominent and coherent copper-gold-moly anomaly where structurally controlled hydrothermal and tourmaline breccias breach the surfaceThe 46 Sou ...
At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.
Pacific Ridge Exploration Ltd. (TSXV: PEX) (OTCQB: PEXZF) (FSE: PQW) (“Pacific Ridge” or the “Company”) has filed an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback